Seemal Rohit Desai MD
Clinical Assistant Professor, Dermatology, University of Texas Southwestern Medical Center
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-919-3500
Fax+1 214-919-3501
Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Medical CenterResidency, Dermatology, 2006 - 2009
Morehouse School of MedicineInternship, Internal Medicine, 2005 - 2006- Morehouse School of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2009 - 2026
AL State Medical License 2006 - 2025
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.Julien Seneschal, Albert Wolkerstorfer, Seemal R Desai, Pearl Grimes, Khaled Ezzedine
Dermatology and Therapy. 2025-05-01 - Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin color.Valerie M Harvey, Jenna C Lester, Tarannum Jaleel, Junko Takeshita, Amy J McMichael
Archives of Dermatological Research. 2025-04-19 - 1 citationsImproving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.Andrew Alexis, Amy McMichael, Neelam Vashi, Tina Bhutani, Adrian O Rodriguez
JAMA Dermatology. 2025-03-01
Press Mentions
American Academy of Dermatology Statement on Benzoyl Peroxide in OTC Personal Care ProductsMarch 10th, 2025- Incoming AAD President Dr. Taylor Pledges to 'Take Care of Dermatologists'March 9th, 2025
- AAD Letter to the Wall Street Journal in Response to “$500,000 Pay, Predictable Hours: How Dermatology Became the ‘It’ Job in Medicine”November 20th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
